Literature DB >> 179953

Comparison of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus.

S G Rabinowitz, M C Dal Canto, T C Johnson.   

Abstract

The pathogenicity of infection produced following intracerebral (i.c.) inoculation of wild-type vesicular stomatitis virus (VSV) or temperature-sensitive (ts) mutants of VSV was compared. ts mutants used were ts 31 (VSV complementation group II) and ts 41 (VSV complementation group IV). The i.c. injection of wild-type VSV in weanling Swiss mice produced a rapidly fatal encephalitis with death of mice in 2 to 3 days. Histopathologically, such mice exhibited minimal changes of encephalitis on light microscopy. In contrast to the highly virulent, rapidly fatal central nervous system (CNS) infection seen after i.c. inoculation of wild-type VSV, infection with ts 31 VSV produced a more slowly progressive CNS infection characterized by hind limb paralysis and death 6 to 9 days after infection. Histopathologically, CNS infection with ts 31 is associated with previously unreported extensive spongiform changes in the gray matter of the spinal cord. The inoculation of ts 41 i.c., on the other hand, did not result in either clinical illness or histopathological changes in the spinal cords or brains of infected mice. The absence of clinical and histopathological lesions following i.c. infection of ts 41 VSV suggests that the capacity to alter the pathogenesis of VSV CNS infection may be a function of only certain ts mutants of VSV.

Entities:  

Mesh:

Year:  1976        PMID: 179953      PMCID: PMC420745          DOI: 10.1128/iai.13.4.1242-1249.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

Review 1.  THE VIRAL CARRIER STATE IN ANIMAL CELL CULTURES.

Authors:  D L WALKER
Journal:  Prog Med Virol       Date:  1964

2.  Temperature-sensitive viruses and the etiology of chronic and inapparent infections.

Authors:  O T Preble; J S Youngner
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

3.  Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate.

Authors:  C R Pringle
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

4.  Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  M E Reichmann; C R Pringle; E A Follett
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

5.  Temperature-sensitive mutants of respiratory syncytial virus.

Authors:  M A Gharpure; P F Wright; R M Chanock
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

6.  Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals.

Authors:  J Mills; V Chanock; R M Chanock
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

Review 7.  Status spongiosus of nervous tissue. Electron microscopic studies.

Authors:  B Adornato; P Lampert
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

8.  Experimental measles encephalitis: a genetic analysis.

Authors:  M V Haspel; R Duff; F Rapp
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

9.  Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase.

Authors:  J J Holland; L P Villarreal
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

10.  Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection.

Authors:  R H Schloemer; R R Wagner
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

  10 in total
  22 in total

1.  Growth and maturation of a vesicular stomatitis virus temperature-sensitive mutant and its central nervous system isolate.

Authors:  J V Hughes; T C Johnson; S G Rabinowitz; M C Dal Canto
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

2.  Polio, still lurking in the shadows.

Authors:  Anthony N van den Pol
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

3.  Persistent infection of a temperature-sensitive G31 vesicular stomatitis virus mutant in neural and nonneural cells: biological and virological characteristics.

Authors:  J Huprikar; S G Rabinowitz; M C DalCanto; M K Rundell
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Virulence of temperature-sensitive mutants of Sindbis virus in neonatal mice.

Authors:  P N Barrett; G J Atkins
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  Sleep and behavior during vesicular stomatitis virus induced encephalitis in BALB/cJ and C57BL/6J mice.

Authors:  Mayumi Machida; Marta A Ambrozewicz; Kimberly Breving; Laurie L Wellman; Linghui Yang; Richard P Ciavarra; Larry D Sanford
Journal:  Brain Behav Immun       Date:  2013-09-18       Impact factor: 7.217

Review 6.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

7.  Role of VSV G antigen in the development of experimental spongiform encephalopathy in mice.

Authors:  O Robain; F Chany-Fournier; I Cerutti; M Màzlo; C Chany
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Is progressive multifocal leukoencephalopathy a chronic disease because of defective interfering particles or temperature-sensitive mutants of JC virus?

Authors:  B W Grinnell; J D Martin; B L Padgett; D L Walker
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

9.  Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination.

Authors:  M C Dal Canto; S G Rabinowitz
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

10.  Neurovirulence mutant of vesicular stomatitis virus with an altered target cell tropism in vivo.

Authors:  O T Preble; L E Costello; D D Huang; M A Barmada
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.